Company intelligence / Profile preview

BioKey Therapeutics

Fremont, California, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

BioKey is a full-service contract research and development organization (CRO) and contract manufacturing organization (CMO) that specializes in the development of generic and value-added specialty pharmaceuticals. The company provides a comprehensive suite of services including formulation development, analytical testing, clinical research (Phase I-IV), and commercial-scale manufacturing. BioKey focuses on optimizing drug delivery systems and navigating the regulatory pathway for Abbreviated New Drug Applications (ANDAs) and 505(b)(2) submissions. Their facilities are FDA-inspected and designed to support both small-scale clinical batches and large-scale commercial production.

Modalities: Small molecule
Industry: Contract Research Organization

Beyond the preview

Go deeper on BioKey Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioKey Therapeutics.

Explore the full profile